Table 3.
Differences in operative and postoperative outcomes between sarcopenic and non-sarcopenic patients
| All cases N = 162 | Non-sarcopenia N = 81 | Sarcopenia N = 81 | P value | |
|---|---|---|---|---|
| Operative procedure | 0.33 | |||
| Pancreaticoduodenectomy | 117 (72.2%) | 62 (76.5%) | 55 (67.9%) | |
| Distal pancreatectomy | 44 (27.2%) | 19 (23.5%) | 25 (30.9%) | |
| Total pancreatectomy | 1 (0.6%) | 0 (0.0%) | 1 (1.2%) | |
| Surgical approach | 0.99 | |||
| Open | 160 (98.8%) | 80 (98.8%) | 80 (98.8%) | |
| Laparoscopy | 2 (1.2%) | 1 (1.2%) | 1 (1.2%) | |
| Operation time (min), median (range) | 0.40 | |||
| 544 (208–833) | 545 (208–741) | 527 (244–833) | ||
| Estimated blood loss (ml), median (range) | 0.91 | |||
| 655 (0–2834) | 650 (0–2834) | 660 (80–2560) | ||
| Postoperative morbidity (CD ≥ III) | 0.25 | |||
| Absent | 128 (79.0%) | 61 (75.3%) | 67 (82.7%) | |
| Present | 34 (21.0%) | 20 (24.7%) | 14 (17.3%) | |
| POPF# (grade B or C) | 0.29 | |||
| Absent | 135 (83.3%) | 65 (80.2%) | 70 (86.4%) | |
| Present | 27 (16.7%) | 16 (19.8%) | 11 (13.6%) | |
| Postoperative hospital stay (days), median (range) | 0.03 | |||
| 23 (7–151) | 24 (11–151) | 21 (7–75) | ||
| Mortality within 30 days | N/A | |||
| Absent | 162 (100.0%) | 81 (100.0%) | 81 (100.0%) | |
| Present | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Reoperation within 30 days | 0.25 | |||
| Absent | 159 (98.1%) | 78 (96.3%) | 81 (100.0%) | |
| Present | 3 (1.9%) | 3 (3.7%) | 0 (0.0%) |
CD Clavien–Dindo classification, POPF postoperative pancreatic fistula, ISGPF International Study Group of Pancreatic Fistula, N/A not applicable #POPF was diagnosed according to the ISGPF definition